Neuehealth Stock Investor Sentiment
| NEUE Stock | 4.86 0.14 2.80% |
About 68% of NeueHealth's investor base is looking to short. The analysis of overall sentiment of trading NeueHealth stock suggests that many investors are alarmed at this time. The current market sentiment, together with NeueHealth's historical and current headlines, can help investors time the market. In addition, many technical investors use NeueHealth stock news signals to limit their universe of possible portfolio assets.
NeueHealth |
Far too much social signal, news, headlines, and media speculation about NeueHealth that are available to investors today. That information is available publicly through NeueHealth media outlets and privately through word of mouth or via NeueHealth internal channels. However, regardless of the origin, that massive amount of NeueHealth data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of NeueHealth news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of NeueHealth relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to NeueHealth's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive NeueHealth alpha.
NeueHealth Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Acquisition by New Enterprise Associates 15, L.p. of 61865 shares of NeueHealth at 0.01 subject to Rule 16b-3 | 10/01/2024 |
2 | HABANOS, S.A. PRSENTIERTE DIE NEUE VITOLA COHIBA VISTOSOS AUF DER INTERNATIONALEN TFWA-AUSSTELLUNG IN CANNES | 10/02/2024 |
3 | Disposition of 263 shares by Jay Matushak of NeueHealth subject to Rule 16b-3 | 10/04/2024 |
4 | Disposition of tradable shares by Jay Matushak of NeueHealth at 5.18 subject to Rule 16b-3 | 10/07/2024 |
5 | NeueHealth CFO sells shares worth 450 | 10/08/2024 |
6 | LAWINENHUND 2.0 DAS NEUE MAMMUT BARRYVOX S2 | 10/15/2024 |
7 | TOURMALINE UND CLEAN ENERGY ERFFNEN NEUE ERDGAS-TANKSTELLEN UND BRINGEN DEN ERSTEN KOMMERZIELLEN ERDGAS-BETANKUNGSKORRIDOR IN WESTKANADA VORAN | 10/24/2024 |
8 | NeueHealth buys full ownership of Centrum Health | 10/30/2024 |
9 | Disposition of 4990 shares by Mikan George Lawrence Iii of NeueHealth at 7.27 subject to Rule 16b-3 | 11/01/2024 |
10 | Charles River Laboratories Q3 Earnings and Revenues Beat Estimates | 11/06/2024 |
11 | NeueHealth Inc Reports Q3 2024 Revenue of 232. ... | 11/07/2024 |
12 | NeueHealth Inc Q3 2024 Earnings Call Highlights Record Financial Performance and ... | 11/08/2024 |
Complementary Tools for NeueHealth Stock analysis
When running NeueHealth's price analysis, check to measure NeueHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeueHealth is operating at the current time. Most of NeueHealth's value examination focuses on studying past and present price action to predict the probability of NeueHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeueHealth's price. Additionally, you may evaluate how the addition of NeueHealth to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |